RT Journal Article
T1 Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.
T2 Guía española para el manejo del asma (GEMA) versión 5.1. Aspectos destacados y controversias.
A1 Plaza, Vicente
A1 Alobid, Isam
A1 Alvarez, Cesáreo
A1 Blanco, Marina
A1 Ferreira, Jorge
A1 García, Gabriel
A1 Gómez-Outes, Antonio
A1 Gómez, Fernando
A1 Hidalgo, Antonio
A1 Korta, Javier
A1 Molina, Jesús
A1 Pellegrini, Francisco Javier
A1 Pérez, Montserrat
A1 Plaza, Javier
A1 Praena, Manuel
A1 Quirce, Santiago
A1 Sanz, José
K1 Asma
K1 Asthma
K1 Clinical practice guidelines
K1 Consenso
K1 Consensus
K1 Evidence-based medicine
K1 Guía de práctica clínica
K1 Medicina basada en la evidencia
AB In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as needed; MILD ASTHMA: glucocorticoid/adrenergic therapy as needed as an alternative in case of low therapeutic adherence to conventional fixed-dose steroids; SEVERE ASTHMA: readjustment of phenotypes, incorporation of triple therapy in a single inhaler, and criteria for selection of a biologic in severe uncontrolled asthma; OTHERS: specific scoring in childhood asthma, incorporation of certain organizational aspects (care circuits, asthma units, telemedicine), new sections on COVID-19 and nasal polyposis.
YR 2021
FD 2021-05-26
LK http://hdl.handle.net/10668/21988
UL http://hdl.handle.net/10668/21988
LA en
LA es
DS RISalud
RD Apr 18, 2025